Pfizer, BioNTech begin human trial for coronavirus vaccine
newsare.net
The trial will include up to 30,000 participants between the ages of 18 and 85 across 120 sites globally.
Pfizer, BioNTech begin human trial for coronavirus vaccine
The trial will include up to 30,000 participants between the ages of 18 and 85 across 120 sites globally. Read more
